UPDATE - Canaccord Genuity Upgraded TranS1 Inc (TSON) to Buy; Reimbursement Gaining Momentum
Tweet
Share
E-mailGet Alerts TSON Hot Sheet
Price: $2.06 --0%
Rating Summary:
6 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Rating Summary:
6 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Join SI Premium – FREE
UPDATE - Canaccord Genuity upgraded TranS1 Inc (NASDAQ: TSON) from Hold to Buy, price target raised from $3.00 to $3.50.
Analyst, William J. Plovanic, said, "We believe the expectations have been reset for TranS1 over the past six months following the announcement of the OIG investigation and rejection of the company’s CPT upgrade request. Furthermore, we believe TranS1 is reaching an inflection point in its reimbursement initiatives, with the pending AMA CPT coding meeting decision expected this week or next and incremental positive coverage policy decisions over the past six months. Lastly, we believe management’s recent actions of re-initiating enrollment in a prospective trial as well as undertaking new physician education programs reflect their confidence in the current strategy to drive reimbursement at both the federal (CPT) and private payor levels."
To see more ratings on TSON, Click Here
Analyst, William J. Plovanic, said, "We believe the expectations have been reset for TranS1 over the past six months following the announcement of the OIG investigation and rejection of the company’s CPT upgrade request. Furthermore, we believe TranS1 is reaching an inflection point in its reimbursement initiatives, with the pending AMA CPT coding meeting decision expected this week or next and incremental positive coverage policy decisions over the past six months. Lastly, we believe management’s recent actions of re-initiating enrollment in a prospective trial as well as undertaking new physician education programs reflect their confidence in the current strategy to drive reimbursement at both the federal (CPT) and private payor levels."
To see more ratings on TSON, Click Here
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Upgrades Apollo Tyres (APTY:IN) to Buy
- Beike (BEKE) PT Raised to $23 at Morgan Stanley
- HSBC Downgrades China Power International (2380:HK) (CPWIF) to Hold
Create E-mail Alert Related Categories
Analyst PT Change, UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
